In contrast, re-programmed p185+ B-ALL cells expressing MCL-1 or BFL-1 were extremely resistant to navitoclax, similar to the resistance of cells lacking the pro-apoptotic effectors BAX and BAK (Figure 3A). This evidence concerns the gene BAK1 and acute lymphoblastic leukemia.